drugset
drugset / Trial / NCT05378061

Hypersensitivity to PACAP-38 in Post-Traumatic Headache

NCT05378061 ↗

Unknown 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

The aim is to investigate whether signaling molecule PACAP-38 induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Timeline

Start
2022-06-16
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject PACAP38 Peptide 10 unknown Intravenous

Indications

No indication recorded.